-
1دورية أكاديمية
المؤلفون: Tatiana P. Berezovskaya, Natalia A. Rubtsova, Valentin E. Sinitsyn, Irina V. Zarodnyuk, Nicolai V. Nudnov, Andrei V. Mishchenko, Yuliya L. Trubacheva, Tatiana A. Bergen, Pavel Yu. Grishko, Svetlana S. Balyasnikova, Yana A. Dayneko, Darya V. Ryjkova, Malika M. Hodzhibekova, Nataliya A. Rucheva, Igor E. Turin, Sergey I. Achkasov, Alexey A. Nevolskikh, Sergey S. Gordeev, Inna V. Droshneva
المصدر: Digital Diagnostics, Vol 4, Iss 3, Pp 306-321 (2023)
مصطلحات موضوعية: rectal cancer, staging, neoadjuvant treatment, surgical treatment, magnetic resonance imaging, radiology, Computer applications to medicine. Medical informatics, R858-859.7
وصف الملف: electronic resource
العلاقة: https://jdigitaldiagnostics.com/DD/article/viewFile/529668/pdfTest; https://doaj.org/toc/2712-8490Test; https://doaj.org/toc/2712-8962Test
-
2دورية أكاديمية
المؤلفون: E. A. Pavlovskaya, Sergey S. Bagnenko, Ilya A. Burovik, Ekaterina A. Busko, Stanislav A. Tiatkov, Pavel Yu. Grishko, Igor V. Berlev, Е. А. Павловская, С. С. Багненко, И. А. Буровик, Е. А. Бусько, С. А. Тятьков, П. Ю. Гришко, И. В. Берлев
المصدر: Medical Visualization; Принято в печать ; Медицинская визуализация; Принято в печать ; 2408-9516 ; 1607-0763
مصطلحات موضوعية: тератогенное воздействие, pregnancy, safety, US, MRI, computer tomography, ionization, scintigraphy, PET, teratogenic effect, беременные, безопасность, УЗИ, МРТ, КТ, ионизирующее излучение, сцинтиграфия, ПЭТ
وصف الملف: application/pdf
العلاقة: https://medvis.vidar.ru/jour/article/view/1408/876Test; https://medvis.vidar.ru/jour/article/downloadSuppFile/1408/2223Test; https://medvis.vidar.ru/jour/article/downloadSuppFile/1408/2224Test; https://medvis.vidar.ru/jour/article/downloadSuppFile/1408/2229Test; Трофимова Т.Н., Халиков А.Д., Семенова М.Д. Возможности магнитно-резонансной томографии в изучении формирования головного мозга плода. Лучевая диагностика и терапия. 2017; 4 (8): 6–16. https://doi.org/10.22328/2079-5343-2017-4-6-15Test; Amant F., Berveiller P., Boere I.A. et al. Gynecologic cancers in pregnancy: guidelines based on a third international consensus meeting. Ann. Oncol. 2019; 30 (10): 1601–1612. https://doi.org/10.1093/annonc/mdz228Test; Parpinel G., Laudani M.E., Giunta F.P. et al. Use of positron emission tomography for pregnancy-associated cancer assessment: a review. J. Clin. Med. 2022; 11 (13): 1–11. https://doi.org/10.3390/jcm11133820Test; de Haan J., Verheecke M., Van Calsteren K. et al. Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients. Lancet Oncol. 2018; 19 (3): 337–346. https://doi.org/10.1016/S1470-2045Test(18)30059-7; Abramowicz J.S., Kremkau F.W., Merz E. Obstetrical ultrasound: can the fetus hear the wave and feel the heat? Ultraschall Med. 2012; 33 (3): 215–217. https://doi.org/10.1055/s-0032-1312759Test; Aiken C.E., Lees C.C. Long-term effects of in utero Doppler ultrasound scanning-a developmental programming perspective. Med. Hypotheses. 2012; 78 (4): 539–541. https://doi.org/10.1016/j.mehy.2012.01.030Test; Tirada N., Dreizin D., Khati N.J. et al. Imaging pregnant and lactating patients. RadioGraphics. 2015; 35 (6): 1751–1765. https://doi.org/10.1148/rg.2015150031Test; Wei K., Mulvagh S.L., Carson L. et al. The safety of definity and optison for ultrasound image enhancement: a retrospective analysis of 78,383 administered contrast doses. J. Am. Soc. Echocardiogr. 2008; 21 (11): 1202–1206. https://doi.org/10.1016/j.echo.2008.07.019Test; Piscaglia F., Bolondi L., Italian Society for Ultrasound in Medicine and Biology (SIUMB) study group on ultrasound contrast agents. The safety of Sonovue in abdominal applications: retrospective analysis of 23188 investigations. Ultrasound Med. Biol. 2006; 32 (9): 1369–1375. https://doi.org/10.1016/j.ultrasmedbio.2006.05.031Test; Sidhu P.S., Cantisani V., Dietrich C.F. et al. The EFSUMB guidelines and recommendations for the clinical practice of contrast-enhanced ultrasound (CEUS) in non-hepatic applications: update 2017 (Long Version). Ultraschall Med. 2018; 39 (2): e2–e44. https://doi.org/10.1055/a-0586-1107Test; Perelli F., Turrini I., Giorgi M.G. et al. Contrast agents during pregnancy: pros and cons when really needed. Int. J. Environ. Res. Public Health. 2022; 19 (24): 16699. https://doi.org/10.3390/ijerph192416699Test; Kanal E., Barkovich A.J., Bell C. et al.; ACR Blue Ribbon Panel on MR Safety. ACR guidance document for safe MR practices: 2007; Am. J. Roentgenol. 2007. 188 (6): 1447–1474. https://doi.org/10.2214/AJR.06.1616Test; Hartwig V., Giovannetti G., Vanello N. et al. Biological effects and safety in magnetic resonance imaging: a review. Int. J. Environ. Res. Public Health. 2009; 6 (6): 1778–1798. https://doi.org/10.3390/ijerph6061778Test; Chartier A.L., Bouvier M.J., McPherson D.R. et al. The safety of maternal and fetal MRI at 3T. Am. J. Roentgenol. 2019; 213 (5): 1170–1173. https://doi.org/10.2214/AJR.19.21400Test; Ray J.G., Vermeulen M.J., Bharatha A. et al. Association between MRI exposure during pregnancy and fetal and childhood outcomes. JAMA. 2016; 316 (9): 952–961. https://doi.org/10.1001/jama.2016.12126Test; Gomes M., Matias A., Macedo F. Risks to the fetus from diagnostic imaging during pregnancy: review and proposal of a clinical protocol. Pediatr. Radiol. 2015; 45 (13): 1916–1929. https://doi.org/10.1007/s00247-015-3403-zTest; Mervak B.M., Altun E., McGinty K.A. et al. MRI in pregnancy: Indications and practical considerations. J. Magn. Reson. Imaging. 2019; 49 (3): 621–631. https://doi.org/10.1002/jmri.26317Test; Синицын В.Е. Безопасность магнитно-резонансной томографии – современное состояние вопроса. Диагностическая и интервенционная радиология. 2010. 4 (3): 61–66. https://doi.org/10.25512/DIR.2010.04.3.10Test; Behzadi A.H., Zhao Y., Farooq Z., Prince M.R. Immediate allergic reactions to gadolinium-based contrast agents: a systematic review and meta-analysis. Radiology. 2018; 286 (2): 471–482. https://doi.org/10.1148/radiol.2017162740Test; Fraum T.J., Ludwig D.R., Bashir M.R., Fowler K.J. Gadolinium-based contrast agents: a comprehensive risk assessment. J. Magn. Reson. Imaging. 2017; 46 (2): 338–353. https://doi.org/10.1002/jmri.25625Test; Cheong B.Y.C., Wilson J.M., Preventza O.A., Muthupillai R. Gadolinium-based contrast agents: updates and answers to typical questions regarding gadolinium use. Tex. Heart Inst. J. 2022; 49 (3): e217680. https://doi.org/10.14503/THIJ-21-7680Test; Potts J., Lisonkova S., Murphy D.T., Lim K. Gadolinium magnetic resonance imaging during pregnancy associated with adverse neonatal and post-neonatal outcomes. J. Pediatr. 2017; 180: 291–294. https://doi.org/10.1016/j.jpeds.2016.10.061Test; Costello J.R., Kalb B., Martin D.R. Incidence and risk factors for gadolinium-based contrast agent immediate reactions. Top. Magn. Reson. Imaging. 2016; 25 (6): 257–263. https://doi.org/10.1097/RMR.0000000000000109Test; Cowper S.E., Boyer P.J. Nephrogenic systemic fibrosis: An update. Curr. Rheumatol. Rep. 2006; 8 (2): 151–157. https://doi.org/10.1007/s11926-006-0056-9Test; Kanal E., Tweedle M.F. Residual or retained gadolinium: practical implications for radiologists and our patients. Radiology. 2015; 275 (3): 630–634. https://doi.org/10.1148/radiol.2015150805Test; Kodzwa R. ACR manual on contrast media: 2018 updates. Radiol. Technol. 2019; 91 (1): 97–100.; De Santis M., Straface G., Cavaliere A.F. et al. Gadolinium periconceptional exposure: pregnancy and neonatal outcome. Acta Obstet. Gynecol. Scand. 2007; 86 (1): 99–101. https://doi.org/10.1080/00016340600804639Test; Thomsen H.S. ESUR guidelines on contrast agents version 10.0. Contrast Media Safety Committee, 2018; 44 p.; Gatta G., Di Grezia G., Cuccurullo V. et al. MRI in pregnancy and precision medicine: a review from literature. J. Pers. Med. 2021; 12 (1): 1–16. https://doi.org/10.3390/jpm12010009Test; Ghaghada K.B., Starosolski Z.A., Bhayana S. et al. Pre-clinical evaluation of a nanoparticle-based blood-pool contrast agent for MR imaging of the placenta. Placenta. 2017; 57: 60–70. https://doi.org/10.1016/j.placenta.2017.06.008Test; Семенова Е.С., Мащенко И.А., Труфанов Г.Е. Магнитно-резонансная томография при беременности: актуальные вопросы безопасности. Российский Электронный журнал лучевой диагностики. 2020; 10 (1): 216–230. https://doi.org/10.21569/2222-7415-2020-10-1-216-230Test; Ratnapalan S., Bentur Y., Koren G. Doctor, will that x-ray harm my unborn child? CMAJ. 2008; 179 (12): 1293–1296. https://doi.org/10.1503/cmaj.080247Test; Brent R.L. Protection of the gametes embryo/fetus from prenatal radiation exposure. Health Physics. 2015; 108 (2): 242–274. https://doi.org/10.1097/HP.0000000000000235Test; Санитарные правила и нормативы. Нормы радиационной безопасности (НРБ–99/2009): cанитарно-эпидемиологичeские правила и нормативы. Москва – Федеральный центр гигиены и эпидемиологии Роспотребнадзора. 2009. 100 c.; ACR-SPR practice parameter for imaging pregnant or potentially pregnant adolescents and women with ionizing radiation [Electronic resource]. URL: https://www.acr.org/Clinical-Resources/Radiology-Safety/Radiation-SafetyTest (accessed: 05.03.2023).; Публикация 103 Международной комиссии по радиационной защите (МКРЗ): Пер. с англ. / Под. общей ред. М.Ф. Киселёва, Н.К. Шандалы. М.: Изд-во ООО ПКФ “Алана”, 2009. 344 с.; Крылов А.С., Наркевич Б.Я., Рыжков А.Д. Определение дозы-облучения плода у беременных женщин с раком молочной железы при сцинтиграфии сторожевых лимфатических узлов. Онкологический журнал: лучевая диагностика, лучевая терапия. 2021; 4 (4); 78–87. https://doi.org/10.37174/2587-7593-2021-4-4-78-87Test; Raman S.P., Johnson P.T., Deshmukh S. et al. CT dose reduction applications: available tools on the latest generation of CT scanners. J. Am. Coll. Radiol. 2013. 10 (1): 37–41. https://doi.org/10.1016/j.jacr.2012.06.025Test; Colletti P.M., Micheli O.A., Lee K.H. To shield or not to shield: application of bismuth breast shields. Am. J. Roentgenol. 2013; 200 (3): 503–507. https://doi.org/10.2214/AJR.12.9997Test; Кондрашов И.А., Мандал В. Неионные низкоосмолярные мономерные йодированные рентгеноконтрастные средства: некоторые аспекты использования при проведении компьютерной томографии у детей. Медицинская визуализация. 2017; 6: 118–129. https://doi.org/10.24835/1607-0763-2017-6-118-129Test; Webb J.A., Thomsen H.S., Morcos S.K; Members of Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR). The use of iodinated and gadolinium contrast media during pregnancy and lactation. Eur. Radiol. 2005; 15 (6): 1234–1240. https://doi.org/10.1007/s00330-004-2583-yTest; Rajaram S., Exley C.E., Fairlie F., Matthews S. Effect of antenatal iodinated contrast agent on neonatal thyroid function. Br. J. Radiol. 2012; 85 (1015): e238–e242. https://doi.org/10.1259/bjr/29806327Test; Kochi M.H., Kaloudis E.V., Ahmed W., Moore W.H. Effect of in utero exposure of iodinated intravenous contrast on neonatal thyroid function. J. Comput. Assist. Tomogr. 2012; 36 (2): 165–169. https://doi.org/10.1097/rct.0b013e31824cc048Test; Зиновьев А.Н., Мотовилова Т.М., Качалина Т.С. Место количественной оценки проходимости маточных труб в определении прогноза лечения трубно-перитонеального бесплодия. РМЖ. Мать и дитя. 2013; 21 (14): 760.; American College of Radiology. Manual on contrast media, version 10.2; American College of Radiology: Reston, VA, USA, 2023. 148 p.; Wang P.I., Chong S.T., Kielar A.Z. et al. Imaging of pregnant and lactating patients: part 2, evidence-based review and recommendations. Am. J. Roentgenol. 2012; 198 (4): 785–792. https://doi.org/10.2214/AJR.11.8223Test; Despierres M., Boudy A.S., Selleret L. et al. Feasibility, safety and impact of (18F)-FDG PET/CT in patients with pregnancy-associated cancer: experience of the French CALG (Cancer Associé à La Grossesse) network. Acta Oncol. 2022; 61 (3): 302–308. https://doi.org/10.1080/0284186X.2021.2004323Test; Zanotti-Fregonara P., Champion C., Trébossen R. et al. Estimation of the beta+ dose to the embryo resulting from 18F-FDG administration during early pregnancy. J. Nucl. Med. 2008; 49 (4): 679–682. https://doi.org/10.2967/jnumed.107.048900Test; Benveniste H., Fowler J.S., Rooney W.D. et al. Maternal-fetal in vivo imaging: a combined PET and MRI study. J. Nucl. Med. 2003; 44 (9): 1522–1530.; Zanotti-Fregonara P., Ishiguro T., Yoshihara K. et al. 18F-FDG fetal dosimetry calculated with PET/MRI. J. Nucl. Med. 2022; 63 (10): 1592–1597. https://doi.org/10.2967/jnumed.121.263561Test; Gropper A.B., Calvillo K.Z., Dominici L. et al. Sentinel lymph node biopsy in pregnant women with breast cancer. Ann. Surg. Oncol. 2014; 21 (8): 2506–2511. https://doi.org/10.1245/s10434-014-3718-2Test; Han S.N., Amant F., Cardonick E.H. et al. Axillary staging for breast cancer during pregnancy: feasibility and safety of sentinel lymph node biopsy. Breast Cancer Res. Treat. 2018; 168 (2): 551–557. https://doi.org/10.1007/s10549-017-4611-zTest; Han S.N., Amant F., Michielsen K. et al. Feasibility of whole-body diffusion-weighted MRI for detection of primary tumour, nodal and distant metastases in women with cancer during pregnancy: a pilot study. Eur. Radiol. 2018; 28 (5): 1862–1874. https://doi.org/10.1007/s00330-017-5126-zTest; https://medvis.vidar.ru/jour/article/view/1408Test
الإتاحة: https://doi.org/10.24835/1607-0763-1408Test
https://doi.org/10.22328/2079-5343-2017-4-6-15Test
https://doi.org/10.1093/annonc/mdz228Test
https://doi.org/10.3390/jcm11133820Test
https://doi.org/10.1016/S1470-2045Test(18)30059-7
https://doi.org/10.1016/j.mehy.2012.01.030Test
https://doi.org/10.1148/rg.2015150031Test
https://doi.org/10.1016/j.echo.2008.07.019Test
https://doi.org/10.1016/j.ultrasmedbio.2006.05.031Test
https://doi.org/10.1055/a-0586-1107Test -
3
المؤلفون: П. Ю. Гришко, А. В. Мищенко, О. В. Ивко, Д. В. Самсонов, А. М. Карачун, Pavel Yu. Grishko, A. V. Mishchenko, O. V. Ivko, D. V. Samsonov, A. M. Karachun
المصدر: Diagnostic radiology and radiotherapy ; Лучевая диагностика и терапия
مصطلحات موضوعية: rectal cancer, method, diagnostics, disease extent assessment, magnetic resonance imaging (MRI), circumferential resection margin (CRM), extramural venous invasion (EMVI), tumour regression grade (TRG), рак прямой кишки, диагностика, оценка распространенности, магнитно-резонансная томография (МРТ), циркулярный край резекции, экстрамуральная венозная инвазия, степень регресса опухоли
الإتاحة: https://doi.org/10.22328/2079-5343-2019-10-4-49-56Test
https://openrepository.ru/article?id=387965Test